Long-term survival of hormone-refractory prostate cancer: A case report

Journal of UOEH

Volumn 23, Issue 1, 2001, Pages 51-58

  Fujimoto, N ^a   Harada, S ^a   Hida, T ^a   Matsumoto, T ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Antiandrogen; Chemotherapy; Hormone refractory; Prostate cancer

Indexed keywords

ANTIANDROGEN; CHLORMADINONE ACETATE; ESTRAMUSTINE PHOSPHATE; ESTROGEN; ETOPOSIDE; FLUTAMIDE; HORMONE; PROSTATE SPECIFIC ANTIGEN; TEGAFUR; URACIL;

AGED; ARTICLE; CANCER SURVIVAL; CASE REPORT; CASTRATION; DRUG RESPONSE; HORMONAL THERAPY; HUMAN; MALE; PROSTATE ADENOCARCINOMA;

EID: 0035103594     PISSN: 0387821X     EISSN: None     Source Type: Journal    
DOI: 10.7888/juoeh.23.51     Document Type: Article

References (23)

1. Total androgen ablation: American experience
2. Cancer statistics 1995
3. Prostate cancer
4. Studies on prostatic cancer: Effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
5. New hormonal therapy in prostatic carcinoma: Combined treatment with an LHRH agonist and an antiandrogen
6. Prediction of prognosis for prostatic adenocarcinoma and combined histological grading and clinical staging
7. Histologic grading of prostate cancer: A perspective
8. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
9. From HER 2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
10. Requirement of ErbB 2 for signaling by interleukin-6 in prostate carcinoma cells
11. Interleukin-6 regulates prostatic-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
12. Activation of the human androgen receptor through a protein kinase A signaling pathway
13. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathway
14. Phorbol ester cause ligand-independent activation of the androgen receptor
15. Prostate specific antigen decline after antiandrogen withdrawal: The flutamide withdrawal syndrome
16. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
17. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens
18. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma in activated by adrenal androgens and progesterone